Vitamin D supplementation reduces intimal hyperplasia and restenosis following coronary intervention in atherosclerotic swine

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Gupta, Gaurav K ^a   Agrawal, Tanupriya ^a   Rai, Vikrant ^a   Del Core, Michael G ^a   Hunter, William J ^a   Agrawal, Devendra K ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALPHA SMOOTH MUSCLE ACTIN; COLECALCIFEROL; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BARE METAL STENTING; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DRUG DOSE COMPARISON; FEMALE; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RESTENOSIS; VASCULAR SMOOTH MUSCLE CELL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; YUCATAN MICROPIG; ADVERSE EFFECTS; ANIMAL; COMPLICATION; CORONARY RESTENOSIS; DIETARY SUPPLEMENT; DISEASE MODEL; DRUG EFFECTS; HYPERPLASIA; INTIMA; PATHOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PIG;

ANIMALS; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; HYPERPLASIA; PERCUTANEOUS CORONARY INTERVENTION; SWINE; TUNICA INTIMA; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84974853777     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0156857     Document Type: Article

References (48)

1. Mathers CD, Loncar D (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3: e442.
2. Nobuyoshi M, Kimura T, Nosaka H, Mioka S, Ueno K, Yokoi H, et al. (1988) Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients. J Am Coll Cardiol 12: 616-623
3. Rupprecht HJ, Brennecke R, Bernhard G, Erbel R, Pop T, Meyer J (1990) Analysis of risk factors for restenosis after PTCA. Cathet Cardiovasc Diagn 19: 151-159.
4. Serruys PW, Foley DP, Kirkeeide RL, King SB 3rd (1993) Restenosis revisited: insights provided by quantitative coronary angiography. Am Heart J 126: 1243-1267.
5. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, et al. (1994) A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease.Stent Restenosis Study Investigators. N Engl J Med 331: 496-501.
6. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, et al. (1994) A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 331: 489-495.
7. Guagliumi G, Farb A, Musumeci G, Valsecchi O, Tespili M, Motta T, et al. (2003) Images in cardiovascular medicine. Sirolimus-eluting stent implanted in human coronary artery for 16 months: pathological findings. Circulation 107: 1340-1341.
8. JonerM, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, et al. (2006) Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48: 193-202.
9. Nebeker JR, Virmani R, Bennett CL, Hoffman JM, Samore MH, Alvarez J, et al. (2006) Hypersensitivity cases associated with drug-eluting coronary stents: A review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol 47: 175-181.
10. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, et al. (2004) Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109: 701-705.
11. Kornowski R, Hong MK, Tio FO, Bramwell O, Wu H, Leon MB (1998) In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 31: 224-230.
12. Schwartz RS, Holmes DR Jr., Topol EJ (1992) The restenosis paradigm revisited: An alternative proposal for cellular mechanisms. J Am Coll Cardiol 20: 1284-1293.
13. Jordan NJ, Watson ML, Williams RJ, Roach AG, Yoshimura T, Westwick J (1997) Chemokine production by human vascular smooth muscle cells: modulation by IL-13. Br J Pharmacol 122: 749-757.
14. Kranzhofer R, Clinton SK, Ishii K, Coughlin SR, Fenton JW 2nd, Libby P (1996) Thrombin potently stimulates cytokine production in human vascular smooth muscle cells but not in mononuclear phagocytes. Circ Res 79: 286-294.
15. Mitsumata M, Fishel RS, Nerem RM, Alexander RW, Berk BC (1993) Fluid shear stress stimulates platelet-derived growth factor expression in endothelial cells. Am J Physiol 265: H3-8.
16. Zittermann A, Schleithoff SS, Koerfer R (2005) Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr 94: 483-492.
17. Zittermann A, Scheld K, Stehle P (1998) Seasonal variations in vitamin D status and calcium absorption do not influence bone turnover in young women. Eur J Clin Nutr 52: 501-506.
18. Douglas AS, Dunnigan MG, Allan TM, Rawles JM (1995) Seasonal variation in coronary heart disease in Scotland. J Epidemiol Community Health 49: 575-582.
19. Hypponen E, Power C (2006) Vitamin D status and glucose homeostasis in the 1958 British birth cohort: The role of obesity. Diabetes Care 29: 2244-2246.
20. Ford ES, Ajani UA, McGuire LC, Liu S (2005) Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 28: 1228-1230.
21. Pilz S, Tomaschitz A, Ritz E, Pieber TR (2009) Vitamin D status and arterial hypertension: A systematic review. Nat Rev Cardiol 6: 621-630. doi: 10.1038/nrcardio.2009.135
22. Bostick RM, Kushi LH, Wu Y, Meyer KA, Sellers TA, Folsom AR (1999) Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol 149: 151-161.
23. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, et al. (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117: 503-511. doi: 10.1161/CIRCULATIONAHA.107. 706127
24. Brennan A, Katz DR, Nunn JD, Barker S, Hewison M, Fraher LJ, et al. (1987) Dendritic cells from human tissues express receptors for the immunoregulatory vitamin D3 metabolite, dihydroxycholecalciferol. Immunology 61: 457-461.
25. Veldman CM, Cantorna MT, DeLuca HF (2000) Expression of 1, 25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys 374: 334-338.
26. Lemire JM, Archer DC, Beck L, Spiegelberg HL (1995) Immunosuppressive actions of 1, 25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. J Nutr 125: 1704S-1708S.
27. Penna G, Adorini L (2000) 1 Alpha, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 164: 2405-2411.
28. Canning MO, Grotenhuis K, de Wit H, Ruwhof C, Drexhage HA (2001) 1-Alpha, 25-Dihydroxyvitamin D3 (1, 25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes. Eur J Endocrinol 145: 351-357.
29. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19: 683-765.
30. Chen WR, Qian YA, Chen YD, Shi Y, Yin da W, Wang H, et al. (2014) The effects of low vitamin D on coronary artery disease. Heart Lung Circ 23: 314-319. doi: 10.1016/j.hlc.2013.08.012
31. Seker T, Gur M, Yuksel Kalkan G, Kuloglu O, Yildiz Koyunsever N, Yildiray Sahin D, et al. (2014) Serum 25-hydroxyvitamin D level and extent and complexity of coronary artery disease. J Clin Lab Anal 28: 52-58. doi: 10.1002/jcla.21643
32. Verdoia M, Schaffer A, Sartori C, Barbieri L, Cassetti E, Marino P, et al. (2014) Vitamin D deficiency is independently associated with the extent of coronary artery disease. Eur J Clin Invest 44: 634-642. doi: 10.1111/eci.12281
33. Gupta GK, Agrawal T, Del Core MG, Hunter WJ 3rd, Agrawal DK (2012) Decreased expression of vitamin D receptors in neointimal lesions following coronary artery angioplasty in atherosclerotic swine. PLoS One 7: e42789. doi: 10.1371/journal.pone.0042789
34. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357: 266-281.
35. Hathcock JN, Shao A, Vieth R, Heaney R (2007) Risk assessment for vitamin D. Am J Clin Nutr 85: 6-18.
36. Gupta GK, Agrawal T, DelCore MG, Mohiuddin SM, Agrawal DK (2012) Vitamin D deficiency induces cardiac hypertrophy and inflammation in epicardial adipose tissue in hypercholesterolemic swine. Exp Mol Pathol 93: 82-90. doi: 10.1016/j.yexmp.2012.04.006
37. Gupta GK, Dhar K, Del Core MG, Hunter WJ 3rd, Hatzoudis GI, Agrawal DK (2011) Suppressor of cytokine signaling-3 and intimal hyperplasia in porcine coronary arteries following coronary intervention. Exp Mol Pathol 91: 346-352. doi: 10.1016/j.yexmp.2011.04.004
38. Michos ED, Melamed ML (2008) Vitamin D and cardiovascular disease risk. Curr Opin Clin Nutr Metab Care 11: 7-12.
39. Carrelli AL, Walker MD, Lowe H, McMahon DJ, Rundek T, Sacco RL, et al. (2011) Vitamin D deficiency is associated with subclinical carotid atherosclerosis: The Northern Manhattan study. Stroke 42: 2240-2245. doi: 10.1161/STROKEAHA.110.608539
40. Reitman JS, Mahley RW, Fry DL (1982) Yucatan miniature swine as a model for diet-induced atherosclerosis. Atherosclerosis 43: 119-132.
41. Schwartz RS, Murphy JG, Edwards WD, Camrud AR, Vliestra RE, Holmes DR (1990) Restenosis after balloon angioplasty. A practical proliferative model in porcine coronary arteries. Circulation 82: 2190-2200.
42. Steele PM, Chesebro JH, Stanson AW, Holmes DR Jr., Dewanjee MK, Badimon L, et al. (1985) Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model. Circ Res 57: 105-112.
43. Bagchi AK, Sharma A, Dhingra S, Lehenbauer Ludke AR, Al-Shudiefat AA, Singal PK (2013) Interleukin-10 activates Toll-like receptor 4 and requires MyD88 for cardiomyocyte survival. Cytokine 61: 304-314. doi: 10.1016/j.cyto.2012.10.013
44. Profumo E, Esposito C, Buttari B, Tosti ME, Ortona E, Margutti P, et al. (2007) Intracellular expression of cytokines in peripheral blood from patients with atherosclerosis before and after carotid endarterectomy. Atherosclerosis 191: 340-347.
45. Battes LC, Cheng JM, Oemrawsingh RM, Boersma E, Garcia-Garcia HM, de Boer SP, et al. (2014) Circulating cytokines in relation to the extent and composition of coronary atherosclerosis: results from the ATHEROREMO-IVUS study. Atherosclerosis 236: 18-24. doi: 10.1016/j.atherosclerosis.2014.06.010
46. Rao VH, Rai V, Stoupa S, Subramanian S, Agrawal DK (2016) Tumor necrosis factor-Alpha regulates triggering receptor expressed on myeloid cells-1-dependent matrix metalloproteinases in the carotid plaques of symptomatic patients with carotid stenosis. Atherosclerosis 248: 160-169. doi: 10.1016/j. atherosclerosis.2016.03.021
47. Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R (2006) Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: A double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 83: 754-759.
48. Thorand B, Zierer A, Huth C, Linseisen J, Meisinger C, Roden M, et al. (2011) Effect of serum 25-hydroxyvitamin D on risk for type 2 diabetes may be partially mediated by subclinical inflammation: results from the MONICA/KORA Augsburg study. Diabetes Care 34: 2320-2322